Background: Correlation between KRAS mutations and pulmonary adenocarcinomas (PA) has been well documented. We have previously shown that majority of the KRAS G12/G13 mutations is transversion (G>T and G>C) in PA compared to colorectal adenocarcinomas (p= 0.011). The aim of this study was to evaluate for possible relationships between transverse mutations and expressions of enzymes associated with DNA methylation and oxidative stress in KRAS mutant PA. Design: A total of 109 PA patients without EGFR TKD mutations (Exon19 and 21) were enrolled in this study. Genomic DNA was used for KRAS G12/G13 codon mutation testing by direct sequencing. A tissue microarray consisting of 62 PA samples including 26 PA with KRAS mutation was evaluated for the expression of DNMT1, DNMT3a, and NQO1 by immunohistochemistry. The correlations between markers expression and clinicopathologic variables were examined by Kruskal-Wallis ranks test and Spearman Rank Order test. Results: Among 26 mutant KRAS gene, 84.6% were transverse mutation. Moreover, 21 of 22 transverse mutation are G>T (>95%). No correlation was present between patients' KRAS mutation status and age or sex. The presence of KRAS mutations, however, was associated with increased expression of DNMT1 (r=0.582, p<0.0001), NQO1 (r=0.436, p=0.0004), and DNMT3A (r=0.35, p=0.0053) in the tumor cells. Nuclear expression of DNMT1 was seen in 25 of tumors (25/62), and majority (77.3%) of them had KRAS mutation (p=0.0054).
Conclusions:
The polyclonal antibody to napsin A is more sensitive but less specifi c than the monoclonal antibody in identifying lung adenocarcinoma. A monoclonal antibody is the better choice for a tumor of unknown origin; whereas a polyclonal antibody is preferred for the distinction of primary lung ADC from squamous cell CA.
Quality Assurance
pairs analyzed showed statistically signifi cant increases in TAT following use of IHC (p<0.05). When IHC was used, 80% of samples had a TAT of 3.15 days (2.29 days for biopsy specimens and 4.11 days for surgical resections). Conclusions: The use of IHC signifi cantly increases TAT in both surgical resection and biopsy specimens with a diagnosis of dysplasia or carcinoma. Our data potentially provides a useful benchmark for additional time required for IHC. Since many specimens require IHC prior to issuing a surgical pathology report, similar studies from other institutions will help evolve TAT recommendations for specimens requiring IHC.
Cytohistologic Correlation of Thyroid Lesions:
The Effect of the Bethesda System for Reporting Thyroid Cytopathology F Bhaijee, K Brown, I Akhtar, A Siddiqi. University of Mississippi Medical Center, Jackson, MS. Background: Fine needle aspiration (FNA) is commonly used in the evaluation of thyroid pathology. This study correlates thyroid FNA cytology results with subsequent histopathologic diagnoses and compares correlation rates pre-and post-implementation of the Bethesda System for Reporting Thyroid Cytopathology. Design: We reviewed all thyroid FNAs performed at a large academic medical center between 01/2006 and 09/2011 and identifi ed patients that underwent subsequent surgical resection. The Besthesda System for Reporting Thyroid Cytopathology was implemented in 2010. Results: Over a 5.75 year period, 156 patients underwent thyroid FNA and subsequent resection. Overall, cytohistologic correlation was achieved in 73% (114/156) of patients. Of the 42 cases with cytohistologic disparity: 15 follicular adenomas were called benign(7), suspicious for papillary thyroid carcinoma (PTC)(4), or unsatisfactory(4) on preceding FNA; 10 PTCs were called benign(2), AUS/FLUS(2), follicular neoplasm(3), or unsatisfactory(3); 13 benign lesions were called FLUS(1), suspicious for follicular neoplasm(1), follicular neoplasm(1), suspicious for PTC(3), or unsatisfactory(7); 2 follicular carcinomas were called either FLUS or benign; 1 poorly-differentiated carcinoma was called medullary carcinoma; and 1 leiomyosarcoma was unsatisfactory on FNA. Cytohistologic correlation pre-and post-Bethesda implementation was 71% (77/109) and 79% (37/47), respectively. Pre-implementation, 32 cases showed cytohistologic disparity: 8 cases called benign on FNA showed follicular adenoma(6), follicular carcinoma(1), or PTC(1) on subsequent resection; 12 unsatisfactory FNAs were benign(5), follicular adenoma(4), or PTC(3); 4 cases called follicular neoplasm were PTC(3) or benign(1); 1 case called suspicious for follicular neoplasm was benign; and 7 cases called suspicious for PTC were follicular adenoma(4) or benign(3). PostBethesda implementation, 10 cases showed disparity: 2 cases called benign on FNA showed either follicular adenoma or PTC on subsequent resection; 3 unsatisfactory FNAs were benign(2) or leiomyosarcoma(1); 4 AUS/FLUS on FNA were follicular carcinoma(1), PTC(2), or benign(1); and 1 case called medullary carcinoma on FNA showed poorly-differentiated carcinoma histologically. Conclusions: Thyroid FNA cytology and subsequent histopathologic diagnoses correlate well overall, with modest improvement post-Bethesda implementation. In our setting, the high prevalence of thyroid pathology and the well-defi ned Bethesda criteria thereof will likely further improve cytohistologic correlation rates over time. Background: The use of frozen sections (FS) on the thyroid is controversial. Most of the FS on thyroid are non-contributory since fi ne needle aspiration biopsy usually guides surgical procedures. However, many surgeons continue to request thyroid intraoperative consultation. Our goal was to investigate the prevalence and value of FS on resected thyroids within our institution in patients who had already undergone fi ne needle aspiration (FNA) and to determine whether or not the use of FS provided any diagnostic or therapeutic value. Design: We gathered the reports of all patients with thyroid FNA and subsequently resected thyroid over a 24 month period within two institutions of our service. Patients were separated into two groups; those whose surgeons requested FS and those who did not. Among these groups, patients were categorized by age, gender, cytology diagnosis, fi nal diagnosis, and specialty of surgeon. Those receiving FS were assessed for major discordances. Major discordance was defi ned as an intraoperative diagnosis of a benign lesion with a fi nal diagnosis of malignancy, or vice versa. Results: 211 patients over a 24 month period received thyroid FNA and subsequent resections (171 female and 40 male patients). Mean age for both genders was 49 (range 16 to 84). Three types of surgeons were identifi ed in the study; endocrine, otolaryngology, and general. There were 78 resected thyroid for which FS were performed; 16 had major FS discordances (20.5%). 16 of 16 discordances were diagnosed as benign on frozen section and were found to be malignant on permanent sections (14 papillary carcinoma; 2 follicular carcinoma). Of the cases with discordance, the cytology diagnosis were as follows: 8 benign, 5 suspicious, 2 malignant, and 1 indeterminate. All FS for which the pathologist made a diagnosis of malignancy maintained concordance on permanent sections. 92% of surgeons requesting FS were otolaryngologists, 4% were endocrine, and 4 % were general. Of the surgeons who did not request FS 35% were otolaryngologists, 28% were general, and 37% were endocrine. Conclusions: Otolaryngologists were far more likely to request FS on thyroid specimens than other surgeons. FS on thyroid glands had an extremely high rate of discordance (20.5%). In all cases of discordance, the FS did not contribute to the fi nal diagnosis or give any additional information as compared to the FNA. Our study serves as a reminder of the ineffectiveness of FS on thyroid. Ineffective FS leads to unnecessary allocation of valuable time and resources as well as increases operative time. D Bombari, B Mora, SC Schaefer, F Mast, H-A Lehr. University of Bern, Bern, Switzerland; CHUV, Lausanne, Switzerland; Inselspital, Bern, Switzerland. Background: We recently described that nuclear grade assignment of prostate carcinomas is subject to a cognitive bias induced by the architectural organization of the tumor. Design: Here, we asked whether this bias is mediated by the unconscious selection of nuclei that "match the expectation". 20 pathologists were asked to grade nuclei in high power fi elds of prostate carcinomas on a computer screen, superimposed over a low power image of the tumor architecture. Unknown to the subjects, each carcinoma was shown twice, once before a background of a well-differentiated, tubule-rich carcinoma and once before the background of an undifferentiated, solid carcinoma. Eye tracking allowed to identify which nuclei the pathologists fi xated on during the 8 second projection period. Results: Nuclear grade assignment was signifi cantly biased by the architectural differentiation of the tumors. "Gravitation" of nuclear grades towards the architectural grade depended on the magnitude of the architectural grade difference of the background images, but not on the experience of the pathologists. Most pathologists tended to fi xate on bigger or darker nuclei when high power fi elds were projected before background images of undifferentiated, solid carcinomas and vice versa. However, the morphological differences of the thus selected nuclei accounted only for about 11% of the total bias induced by the tumor architecture. Conclusions: We conclude that the selection of " matching nuclei " represents nothing but an unconscious effort to vindicate the bias induced by the architectural growth pattern.
Eye-Tracking Experiments Underscore the Bias That Architecture Exerts on Nuclear Grading in Prostate Cancer

A Comparative Study of Tissue Microarray (TMA) Versus Conventional Immunohistochemistry (IHC) for Evaluation of Mismatch Repair (MMR) Systems in Colorectal Cancers (CRCs)
S Brownschidle, M Evans, T Ashikaga, A Iyer. Fletcher Allen Health Care, Burlington, VT. Background: 15-20% of CRCs show microsatellite instability (MSI), a subset associated with better outcomes, poor response to 5-FU and includes Lynch Syndrome. Whole slide (WS) IHC for MMR proteins (MLH1, MSH2, PMS2, MSH6) is popular, however TMA is a cost effective option which allows for high throughput analysis and may be a viable option as institutions adopt universal screening. Little is known about optimal sampling when constructing a TMA. We evaluated concordance rates between WS IHC and TMA and explored the effect of TMA core sites (center versus advancing edge) on concordance. Design: MMR protein expression was analyzed in 52 unselected cases of primary CRC, fi rst by WS IHC and then by TMA on the same block. TMA included four (1 mm) cores per case, two from the center and two from the advancing edge. Staining was graded as positive, negative (absence of tumor nuclear staining with concurrent positive labeling of surrounding normal tissue) or equivocal (indeterminate staining pattern, insuffi cient tumor for evaluation). Results: Of the 52 cases, 36 (69%) stained positive for all proteins, 14 (27%) had concurrent loss of MLH1 and PMS 2 and 2 (4%) had concurrent loss of MSH2 and MSH6 by WS examination. Comparison of WS versus TMA showed an overall concordance of 96%, 98%, 96% and 98% for MLH1 (see fi gure with TMA on left and WS on right), MSH2, MSH6 and PMS2 respectively, with only 4 discordant cases. Features associated with discordance included weak patchy staining of MSH6 and MSH2, background lymphocytes obscuring interpretation, and inadvertent coring outside the tumor area. No improvement in staining was found between cores taken from the tumor advancing edge versus center.
Conclusions: MMR protein expression by TMA yields comparable results to that of WS IHC and thus may be feasible for diagnostic purposes in a clinical practice setting. While studies have suggested the advancing tumor margin may be more consistently immunoreactive compared to the tumor center, we found no difference in concordance between these locations. In fact, cores taken from the tumor periphery were more likely to miss the tumor and better results may be obtained from the tumor center or combining center and advancing edge. WS Campbell, SM Lele, WW West, LM Smith, SH Hinrichs However, their data sets have either been limited or highly focused on single organ/ tissue types and have not established equivalence between WSI and light microscopy (LM) for general diagnostic purposes. The purpose of this study was to determine the diagnostic concordance between pathologic interpretations using WSI and LM in routine surgical pathology practice with a broad array of tissue types and cases. Design: 215 consecutive previously signed out surgical pathology cases were included in the study. A broad array of case types and tissue sources was represented. All slides from each case were scanned (digitized at 20x) and presented to two senior pathologists (who had not seen any of the cases previously in any format) for diagnosis using WSI as the sole diagnostic tool. Diagnoses rendered by WSI were compared to the original LM diagnoses (recorded in archival surgical pathology reports) and concordance determined by a third senior pathologist. Results: Concordance between WSI and LM was 98% and concordance between the two WSI pathologists was 99%. Five (5) cases were determined to have discordant diagnoses, two of which were clinically signifi cant, between those recorded using WSI and archived LM diagnoses. Discordant cases resulted from interpretive criteria or diagnostic error whereas the WSI modality did not contribute to these diagnostic differences. Problems encountered by the pathologists were primarily related to the inability to clearly visualize microscopic details at higher power due to poor digital magnifi cation of the 20x slide scans and diffi culty in digital image navigation. Advantages of WSI noted include the ability to visualize a very low power image (lower than that provided by LM), ease of measurement using the built in scale and the comfort of viewing slides from any place.
Diagnoses Rendered by Whole Slide Imaging (WSI) Alone Are Accurate for Use in a General Surgical Pathology Practice
Conclusions:
This study supports the use of WSI in general surgical pathology. Improvements in image navigational ability and clarity in visualization of microscopic detail at higher power would help in further advancing the adaptability of this method to a general surgical pathology practice.
Genetic Markers of Cancer -A Molecular Oncology Laboratory Adjusts to Changing Demands of Integrated Hospitals, Medical Centers and Outreach Services
M Cankovic, L Whiteley, J Beher, DA Chitale. Henry Ford Hospital, Detroit, MI. Background: Molecular oncology testing is exponentially increasing to aid in diagnosis and targeted therapy. In complex, budget limited health systems molecular labs are under pressure to cut costs. To align with our system's goal of integration and consolidation we aimed to re-examine and streamline already existing work processes and pathways to reduce waste due to lack of understanding, miscommunication, missing information, and miss delivered specimens. The ultimate goal is to provide timely and seamless service to our customers with zero defects. Design: Following the specimen trail we focussed efforts on 1) Increasing clinician awareness of test availability and specimen requirements (lectures, consultation, information brochures, internet resources); 2) Educating nursing, laboratory, administrative personnel by a) clearly defi ned standard processes (value stream maps, written instructions, internet links); b) monitoring different sites for test requisition completeness and specimen acceptability; 3) Establishing contact with leadership at off site locations; 4) Expanding already existing processes to include remote locations (TAT monitoring; provision of special blood collection tubes); 5) Reinforcing lab's commitment to superior customer service and LEAN practices (refresher training). Results: Clinician awareness was shown by increased utilization of our test menu with appropriate test selection (e.g. vIII EGFR vs EGFR exon 19/21 mutation), and reduced phone call/E-mail questions. There was 80% decrease in missing information (ICD9 codes, clinical information). Process fl ow maps facilitated tissue selection (tumor in block, little/no necrosis) making >90% of specimens acceptable for testing. LEAN practices reduced delay in processing from 31% to 5% in the past 2.5 years even when specimens needed to arrive from different sites and through different pathways. Although volumes increased by about 20% per year our TATs remained constant at 2 to 3 business days (vs the industry standard of 7-14 days). Conclusions: Correct test ordering and timely specimen delivery often necessitate collaboration with individuals separated by geography, leadership structure, and educational levels. By taking initiative, our laboratory has ensured that latest developments in molecular oncologic testing quickly translate into benefi ts to cancer patients. By eliminating non-value added waste we have been able to maintain record short turn around times even with increasing testing volumes and new hospitals and medical centers being integrated into our health system.
Standardized Prosection Protocol Increases Detection Rate of Positive Circumferential Margins in Whipple Specimens
DH Carpenter, I Nalbantoglu, EM Brunt. Washington University in St. Louis, St. Louis, MO. Background: Adenocarcinoma of the pancreas has a dismal prognosis, with high recurrence rates even when surgical margins, including circumferential resection margins (CRM), are reported negative (R0). In the literature, reported rates of microscopically positive margins (R1) vary widely and are often lower than recurrence rates, raising the question of R1 disease being classifi ed as R0 due to sampling error. The traditional protocol (TP) for prosection of pancreatoduodenectomy (Whipple) specimens included an X section through the duodenum, pancreatic duct, and common bile duct for tumor visualization, gross assessment of the margin status, and radial or en face sampling of the CRM based on prosector judgment. A newer standardized protocol (SP) is performed by serially sectioning the entire pancreatic head and peripancreatic fat perpendicular to the opened duodenal segment and completely embedding the sectioned tissue surrounding the tumor for complete radial assessment of the CRM. The aim of this study is to evaluate whether the new SP increases detection of R1 disease. Design: Whipple cases diagnosed as adenocarcinoma arising in the pancreatic head or ampulla were evaluated; 115 consecutive cases (predominantly since divisional protocol change Oct 2009) were included in the SP group; consecutive Whipple specimens following the TP from the prior year were the comparator group (n=70). Cases with surgically evident positive margins (R2), non-adenocarcinoma cases, and primary common bile duct or small bowel (excluding ampulla) were excluded from both groups. The surgeons for both groups were the same. Positive circumferential margins, defi ned as carcinoma ≤1mm from inked margins, were tallied by site (posterior, portal vein groove, uncinate) and compared using Fischer's exact test. The total number of blocks submitted for each Whipple specimen was also recorded and the mean number of blocks for SP and TP was calculated and compared using student's t test. Results: The TP group had 22 cases with at least one CRM positive for tumor (31.4%) while the SP group had 57 cases with at least one CRM positive (49.6%) (p=0.02). On average in the TP group, 23.4 blocks were submitted per Whipple and, in the SP group, 42.8 blocks were submitted (p=0.0001). Conclusions: Evaluation of entire circumferential resection margins CRM in radial sections increases detection rate of R1 disease in a statistically signifi cant fashion. The radial assessment of all margins increases the number of blocks submitted by nearly two-fold.
Retrospective Blinded Review of Major Errors in Anatomic
Pathology: Experience of a Tertiary Care Facility S Chaudhary, LB Kahn, T Bhuiya. Hofstra-North Shore LIJ School of Medicine, Lake Success, NY. Background: Quality control and quality assurance are integral to the practice of Anatomic Pathology, a discipline in which it is diffi cult to defi ne criteria's for evaluating these parameters. This study is focused on pathologist's interpretational diagnostic errors. We present a unique model of quality assurance in which the pathologists in the department perform a blinded review of major discrepancies which served to heightened awareness of patient consequences and reduce the number of errors. Design: All types of errors including false positive/false negative and any error which was of clinical consequences were included in the study. The cases were blinded and given numeric designation. All pathologists were required to review the pertinent slides with the same information that was available to sign out pathologist. Based on the pathologist's consensus opinions, a fi nal performance improvement report was generated. Impact on patient management was considered signifi cant if error necessitated second surgery or an inappropriate surgery was performed because of incorrect diagnosis. Also, delayed treatment resulting from inappropriate diagnosis was considered as signifi cant. If the diagnosis was corrected within short time frame and there was no change in management, the error was considered to be clinically insignifi cant. Results: There were a total of 303 cases over the past 18 years. The cases were divided into various subspecialties and source of error (frozen section or permanent section) was noted. Conclusions: This study highlights the positive impact of systematic review in reducing pathologist's interpretational error and in identifying potential sources of error. Anonymous review process encourages active participation. To conclude, besides the routine quality control and assurance parameters, these cases can be used as an objective tool for monitoring professional competency and provides objective criteria for performance improvement for pathologists. 
Results:
We found that 9% of cases had a discrepancy in diagnosis, when comparing the initial working diagnosis to the second opinion (subject to revision pending resolution of diagnostic changes of uncertain signfi cance). In 3% (n=21) of cases a major discrepancy, expected to alter treatment, was identifed. Signifi cant differences in discrepancy rates were found between organ systems (p<0.01) although discrepancies were identifi ed in nearly all major organ systems. Gynecologic cases had the highest rate of discrepancy at 37%, dermatology cases 26%, and genito-urinary cases were 19% discrepant. The most common reason for a discrepant diagnosis was disagreement about classifi cation.
73% of the referred cases represented a single procedure, 25% represented 2-3 different procedures. Additional testing was performed on 10% of the cases, and 5.4% of the cases had already been seen by a second consultant. Conclusions: Diagnostic review generates a signifi cant amount of discrepancy and impacts clinical management. Discrepancies are more common in some case types but may not provide reliable predictors to pre-select cases for review. We examined the effectiveness of these methods in improving the productivity of histotechnology services. Design: We evaluated the turn-around times (TAT) for the processing of surgical tissue blocks over a 5 month period. To affect a reduction in the backlog of uncut blocks and to achieve a 24 hour processing TAT, we employed Lean methods, including creating a visual workplace; 5S of the laboratory; introduction to Toyota work principles; workspace redesign and standardization; employee engagement in work redesign; and assessment of task staffi ng requirements. Lean Implementation specialists performed root cause analysis to investigate methods of reducing TAT. Pathology residents instituted quality improvement studies to identify areas of over-blocking of surgical specimens.
Results: Initially, we found a backlog of 1989 surgical specimen blocks. Productivity of technologists ranged from 30 slides per day to 150 slides per day with a staff of 14 FTEs. Within the fi rst month, the 5S of the lab created four additional cutting stations that produced a more conducive work area. Employee education encouraged participation from the frontline staff in the evaluation of factors contributing to the backlog of work and in workspace standardization. Reassessment of task staffi ng requirements removed technologists from 2 assignments that were transferred to laboratory assistants thereby freeing up additional time to cut blocks. Improvement specialists created a visual workplace with daily productivity numbers for the cutters as well as graphs indicating the number of blocks received, in arrears, and cut for the week. Unscheduled absences, as well as the revocation of overtime, were addressed with personnel in an attempt to change the culture of non-attachment to job responsibilities. Pathology residents' quality improvement studies identifi ed areas of over-blocking for placentas, fi broids, and submission of specimens deemed unnecessary for pathologic review. Within the fi ve month period the entire backlog was erased and a 24 hour TAT maintained. Productivity of technologists increased to 80 -165 slides per day.
Conclusions:
We showed that the application of Lean methods resulted in increased productivity. The involvement of front line staff in work redesign created a culture of process ownership. The performance of quality improvement studies and root cause analysis resulted in increased effi ciency. Interventions resulted in an overall 84% reduction in specimen defects.
The success in targeting specimen safety is attributed to the team approach to standardizing the numerous specimen hand-offs. The data-driven PDCA approach to monitoring defects and changes is effective in driving and sustaining interventions to ensure that processes are maintained and followed. This also requires ongoing education and support of all in an effort to achieve a zero defect goal. , faculty, specimen number and category of pending issues. The pathology information system at the cancer hospital was programmed to automatically upload these variables from incomplete cases into the Handoff Portal system. At the other hospitals, the variables were manually entered by the transferring resident. On the last working day of each month, the transferring resident confi rms their incomplete case data, the receiving resident reviews the list online, and then a verbal discussion occurs. These actions are tracked online with compliance measured by the percentage of total trainees who completed a handoff at the end of the month via both written and verbal documentation. Results: Since July 1, 2011, the system has been used to track handoffs at the end of each of three 1-month rotation cycles involving 12 rotations at 3 hospitals. A total of 451 cases to be handed off by 28 trainees were tracked. Over the initial 3 months the compliance rate was 93%, 93%, and 86%. Non-compliance trended toward the more senior trainees, in particular, fellows. Conclusions: A web-based tracking system can facilitate transfer of patient care between residents at the end of rotations. Although automated data entry by linkage to the existing pathology information system reduces labor on residents, the handoff itself represents a system and culture change which may not be as readily adopted by senior trainees. Further study into benefi ts for turnaround time and quality assurance are needed. Background: Increased clinical demand to diagnose lymphoma from core needle biopsy(CNB) and fi ne needle aspiration(FNA) samples requires collaboration between radiologists, cyto-and hematopathologists to ensure collection of adequate sample and triage for ancillary studies. No criteria for adequacy are available and the sequence for best tissue retrieval and workfl ow is not well defi ned. As part of our performance improvement, we reviewed our work to identify quality gaps and points of intervention to increase the diagnostic accuracy of lymphoma. Design: Review of 2010-2011 electronic data identifi ed 108 CNB and FNA samples for involvement by lymphoma. Excluded from this study were bone marrow biopsies and metastatic carcinomas; included were samples from superfi cial and deep seated masses/organ lesions. When available, we reviewed pathology and radiology reports for history, location, quantity of sample collected, fl ow cytometry, accuracy of correlation between intraoperative cytology interpretation and fi nal diagnosis and/or follow-up resections. Findings were assessed by our radiologists, cyto-and hematopathologists to develop/apply an improvement plan. Results: 24% of cases had prior history of lymphoma; others were from patients with lymphadenopathy. Most samples were superfi cial (65%) and the number of cores varied (3-multiple). The needle gauge used was 19-20. In 47 cases, fl ow samples collected as CNB were diagnostic in 31%. Out of 61 fl ow samples collected as FNA, 67% were diagnostic. The diagnosis was established in 93/108 cases (86%) and 5/15 nondiagnostic samples had lymphoma on surgical follow-up. Intraoperative consultation by cytopathologists was performed in 104/108 cases and correlated with fi nal diagnosis in 72% cases. Conclusions: As a result of this review, we built a new requisition for clinical history documentation of lymphoma and CBC. Marked difference in fl ow-cytometry results where FNA rather than core biopsies were submitted required a new lymphoma biopsy protocol in Radiology. Flow cytometry samples by FNA will be collected fi rst, followed by a CNB using a larger needle gauge(18). In Cytology, verifi cation for adequacy on fl ow sample in addition to core biopsy touch preps was implemented, and a transfer policy of cases between cyto-and hematopathology staff was created. In Histology, separating core biopsies in 2 blocks was done to secure more tissue for ancillary studies. The effect of the implemented measures will be assessed early January 2012. The impact on laboratory resources, time, and cost for examining these specifi c specimen types are theorized to be signifi cant, although this has not been studied. Design: We evaluated the clinical signifi cance and the effi ciency of processing and examining specimens of limited or no clinical value in our tertiary hospital-based Canadian laboratory. We considered 5 specimen types as not requiring submission or gross examination (e.g., aneurysm contents and teeth) and 8 specimen types as requiring gross examination only (e.g., hernia sacs and intervertebral discs). We measured the number of blocks submitted for each specimen type, non-pathologist workload units as a quantifi er of laboratory resource utilization (each unit represented one minute of time and $2.65 Canadian), and clinical signifi cance of pathologist fi nal tissue diagnosis.
Effectiveness and Effi ciency in the Evaluation
Results:
We processed 274 specimens that generally did not require laboratory submission at a cost of $24,645 and 155 laboratory work hours. We processed 577 specimens that generally required a gross-only examination at a cost of $64,802 and 406.8 laboratory work hours, of which 99.8 hours and $15,872 was spent on block submission. Revision of specimen processing for specimens of limited or no clinical value could potentially save our institution 254.8 laboratory work hours and $40,517 per year. Of the 13 specimen types studied, processing tonsil and adenoid specimens demonstrated the most signifi cant impact on laboratory resources with 307 blocks, 134.6 laboratory work hours, and a cost of $21,399. One incidental dysplastic nevus was found within an abdominal pannus specimen, otherwise there were no other unexpected critical diagnoses. In the tonsil group, we found 6 malignant cases, all with at least a suspicious for malignancy clinical history. Conclusions: Our fi ndings indicate that tissue block submission and gross examination of specimens generally considered of limited or no clinical value resulted in increased laboratory ineffi ciencies and costs. If clinicians provide pertinent clinical patient history, lab personnel could perform no or gross-only examination with considerable cost savings and without a sentinel event. Background: Tissue processing by histology labs is a complicated process, involving replacement of water with a tissue-solidifying medium to allow thin sections to be cut and mounted onto glass slides. This process has the potential to alter tissues. To our knowledge, no previous study has evaluated factors potentially associated with changes in tissue dimensions during processing. Design: We prospectively analyzed 120 skin specimens with a minimum excisional depth of 0.5 cm. We measured the depth from superfi cial epidermis to deepest point of: 1) intact gross specimen (gross-I), 2) deepest gross section after sectioning (gross-S), and 3) histologic section of the corresponding tissue block mounted on a glass slide (hist-D). Change in dimension (CID) was calculated as the difference between hist-D and gross-S. Gross-I and gross-S were both negatively correlated with CID, (rho=-0.27 (95% CI: -0.44, -0.91) and -0.29 (95% CI: -0.46, -0.12), respectively). The difference in mean CID between highest and lowest technologists was 3.55.
Conclusions:
Processing of tissues for histological analysis is an intricate process with signifi cant potential to change dimensions, and thus altering diagnoses and patient management. We found a negative correlation of both gross-I and gross-S with CID, implying that specimens with greater excisional depth and greater depth of deepest section undergo the least absolute change in size after processing. Age, sex, and anatomic site did not signifi cantly infl uence the CID. Background: Gross tissue examination and block submission protocols of common specimens, such as hysterectomy specimens for leiomyomata, are often not-standarized in actual practice. We assessed currently used gross descriptors and number of submitted blocks for hysterectomy specimens with leiomyomata to measure current variability in practice and to establish a standardized protocol in order to improve quality. Design: We conducted a one-year retrospective study to assess the gross description and tissue block submission practices for 175 hysterectomy specimens for leiomyomata. Gross examinations were performed by 4 residents and 3 pathologists assistants. We reviewed pathology reports using a standardized checklist to assess 5 standard internal leiomyoa gross descriptors (eg. number, size, color, texture, and hemorrhage/necrosis), circumscription status, and number of blocks submitted of leiomyomata. We performed descriptive statistics including measures of central tendency and dispersion. Results: We found that only 5% of the leiomyomata had the 5 standard descriptors, 11.4% had 4 descriptors, 22.8% had 3 descriptors, 42.8% had 2 descriptors, and 17.0% had 1 descriptor. Description of the circumscription status was present in only 10.2% of leiomyomata. In single leiomyoma specimens, 15.7% had 3-4 submitted blocks and 13.5% had more than 5 submitted blocks submitted. We found that the number of submitted blocks per leiomyoma increased as the size of leiomyoma increased; for a large leiomyoma (> 10 cm) the number of blocks ranged from 15-19, without worrisome changes in gross descriptors. One-third of specimens with a single leiomyoma had more than 5 blocks submitted.
We found a lack of standardization and high variability in the use of gross descriptors in the examination of leiomyomata, with the majority of leiomyomata poorly described. Over blocking occurred in large leiomyoma specimens and in onethird of small single leiomyoma specimens. We conclude that a more rigous adoption of standardized grossing protocols for specimens with leiomyomata would improve quality and decrease laboratory ineffi ciencies. (50) cases with cervical biopsies (103 total specimens) were imaged at 20x magnifi cation using BioImagene iScan Coreo Au scanners. Two examiners then blindly and independently evaluated the WSI using image-viewing software (Virtuoso). The examiners were aware of prior Pap test results for all cases. The histologic diagnoses were then compared to the original glass slide diagnoses. All diagnoses were stratifi ed as: Negative, HPV/CIN 1, CIN 2, and CIN 3. Results: One hundred and three (103) scanned specimens were collected. Of these, 1 slide had not been scanned and 3 were lacking coverslips or were overstained. Of 200 WSI diagnoses made, no specimen originally diagnosed as high grade dysplasia was called negative. There were 33 minor discrepancies and 14 major (calling a positive fi nding "negative" or two categorical differences). Seven cases (6.8%) could have had different clinical treatment based on WSI interpretation: 5 cases of HPV/CIN 1 were upgraded to CIN 2/3 and 2 cases of CIN 2/3 were downgraded to HPV/CIN 1 by at least one observer. The overall diagnostic accuracy was 83.5%, using the original glass-slide diagnosis as the gold standard. Conclusions: Although whole slide imaging offers a promising new tool for pathologists, validation can be challenging. Here we have shown that for cervical biopsies, where interobserver variability is known to be substantial using glass slides, it is diffi cult to disentangle the effect of WSI image quality from interobserver variability. We consider our results suffi cient to validate WSI as being equivalent to glass slides, but an objective threshold for "acceptable" variability in WSI validation has not been established. Additional studies on intraobserver validation are needed to determine if this is a superior approach. Conclusions: There was no clinically signifi cant decrease in overall plasma or plasma with an INR≤2 transfused before and after implementation of educational strategies. However, there was a clinically signifi cant decrease (17 vs 6) in plasma utilization by medicine, which was specifi cally targeted by educational efforts. Surgery showed an increase in the number of units transfused (26 vs 44) which may refl ect an unintended result of educational efforts which stressed that INR value ≤2 requires more units of plasma to approach a normal INR. Our data suggests that educational strategies based on clinical trends of plasma utilization improve compliance with evidence based guidelines and help identify additional specialties that need focused educational efforts.
A Resident-Driven Process Improvement Project Decreases Cassette Labeling Errors
A Hiniker, K White, C Oto, T Morken, L Perkocha. UCSF, San Francisco, CA. Background: In healthcare, there is increased recognition of the value of process improvement to increase effi ciency and improve patient safety. An important challenge for Anatomic Pathology (AP) laboratories is to adopt these techniques and to provide education and experience in this discipline to residents. AP residents identifi ed this need in the context of specimen cassette labeling in the gross room. We used process improvement techniques to identify and resolve both systematic and individual sources of cassette labeling errors, resulting in a measurable and sustained decrease in errors at our institution. Design: "Errors" were defi ned as any labeling defi ciency that required correction, thus creating non-value-adding labor. These included incorrectly numbered or color-coded cassettes and discrepancies between the histology Laboratory Information System (LIS) worklist and the cassettes received in our off-site histology lab. Institutional data from 360,743 cassettes for 61,581 cases from academic years (AY) 2008-10 were analyzed. The average error rate for AYs 2008-09, 4.1%, was designated as the baseline error rate, with the goal to reduce this error rate by 25%.
A resident committee examined gross room cassette-labeling procedures to identify error-prone steps in specimen processing and transfer to the histology laboratory. Each step was analyzed for process ineffi ciencies and physical or technological limitations leading to error. "Best practices" were identifi ed by observing the procedures of individuals with low baseline error rates, and used to institute systematic changes in process, procedure, and environment.
Results:
The following interventions were made following analysis: replacement/ relocation of cassette racks to improve ergonomics, maintenance of cassette labelers to reduce printing malfunctions, LIS programming and procedure changes to improve synchronization of cassette submission with histology worklists, and monthly data analysis with anonymous feedback of individual errors as compared to department averages. These changes reduced the error rate by 30% in AY 2010, and resulted in intangible changes in resident and PA awareness of the causes and impact of labeling error. Conclusions: Over a 12 month period, this resident-driven project applied process improvement techniques to reduce the block labeling error rate by 30%, improving both laboratory effi ciency and patient safety. An additional benefi t was the development of a culture of continuous improvement, which resulted in increased housestaff enthusiasm and engagement in error reduction. Background: Retrospective review of routine non-gynecological (non-gyn) cases is infrequently performed in cytology laboratories. We sought to examine the utility of retrospective review of non-gyn cases in our laboratory over a four year period. Design: We performed a retrospective review of one randomly selected non-gyn case per day (1% of total cases). Urines were excluded. The slides were examined for interpretation accuracy and the requisitions were compared to the electronic report. Diagnostic differences required consensus review (2-3 observers) to be classifi ed as interpretation differences. Corrected reports were issued where management may have been impacted. Results: Among the 1004 cases reviewed (2007-10), 90 (9%) issues were identifi ed as follows: 49 (55%) accessioning errors (37 typographical errors, 10 incorrect site, 2 incorrect patient/physician identifi ers), 16 (18%) interpretation differences/terminology misuse, 14 (16%) report errors (11 typographical errors, 3 negative with comment about atypia), 4 (4%) cases not signed out, 4 (4%) illegible handwriting and 3 (0.5%) incorrect patient identifi ers. There were 15 (1.5%) corrected reports issued for 7 accessioning/ report errors and 8 interpretation difference/terminology misuse (4 thyroid, 2 breast, 1 soft tissue, 1 fl uid). Conclusions: A review of randomly selected non-gyn cases identifi ed issues in 9% of cases. Rarely, this required a corrected report (1.5%) with over half due to interpretative differences or terminology misuse. Accessioning errors, especially typographical errors, were the most common issues identifi ed at review. Changes to our practice from this analysis include: terminology standardization, recommendations for internal second opinion on certain thyroid diagnoses and double-checking of report against requisition prior to sign-out. Conclusions: ER, PR, and Her-2/neu interpretation is subject to interobserver variability, this study resulting in small but signifi cant discordance rate of 8.6%. As their interpretation may change clinical management review should be performed for patients seeking second opinion or care at another institution. Since then, there has been an increasing demand for hospital administration to impose this responsibility onto the pathologist, as reporting a signifi cant diagnosis is an essential component in patient care. Yet, the pathologist may spend time trying to communicate a signifi cant diagnosis to a clinician, at times with no success. Thus, the current challenge is defi ning the pathologist's role in reporting a signifi cant diagnosis and understanding the most effective means of communicating these results to the clinician. Design: An eleven-item survey was distributed to all medical specialties in our institution. The survey consisted of closed-ended questions relating to the role of the pathologist and effectiveness of signifi cant diagnosis notifi cation. In addition, our department developed a centralized system for communicating a signifi cant diagnosis and this survey was used to analyze the effectiveness of this system. Results: A total of one hundred and twenty seven clinicians and eleven pathologists responded to the survey. Most pathologists (73%) consider our mechanism of reporting a signifi cant diagnosis to be effective. 41% of clinicians reported that our mechanism of reporting a signifi cant diagnosis is not well defi ned. The most effective method of reporting a signifi cant diagnosis was reported as email (63% of clinicians and 73% of pathologists,) however both clinicians and pathologists agree that a fl ag is needed to attract the clinician's attention if the report is sent via email.
Effectiveness of Reporting Signifi cant Diagnosis in
Conclusions:
In the continuously growing fi eld of pathology, the pathologist has had increasing responsibilities in patient care. The perception of this clinical survey reveals that it is the pathologist's responsibility to monitor the clinician's response to a signifi cant diagnosis notifi cation. Subsequently, it is crucial for our clinicians to be well introduced to a centralized system of reporting a signifi cant diagnosis in order to receive this information in a timely manner. Accordingly, although multiple modalities exist to report a signifi cant diagnosis, standardization of reporting is crucial to most effectively improve the pathologist's communication with the clinician. As a result, this will optimize patient care. Ultimately, increasing responsibilities and demands from hospitals may continue to change future practice. Conclusions: In this study, thirty-eight percent of reviewed parathyroidectomy specimens were reclassifi ed as neoplastic when reviewed by an endocrine pathologist as compared to general surgical pathologists. This is suggestive of the improved diagnostic accuracy of sub-specialized pathologists. These fi ndings support the present tendency towards sub-specialized pathology sign-out currently found in many academic centers.
Reprocessing Unsatisfactory ThinPrep Papanicolaou Smears: A Tool for Reducing Unsatisfactory Rate and Enhancing Disease Detection
A Kovalovsky, C Steele, KK Khurana. SUNY Upstate Medical University, Syracuse, NY. Background: Longitudinal studies have shown that cervical cytology specimens classifi ed as unsatisfactory have an increased risk of being associated with disease, including carcinoma. We conducted this study to assess the effect of reprocessing ThinPrep slides on the unsatisfactory rate and subsequent detection of epithelial cell abnormality over a 3-year period at our institution.
Design:
The unsatisfactory rate prior to reprocessing was 2.3 % (627 of 24345). After reprocessing all the unsatisfactory smears, the reprocessing rate was reduced to 0.07% (17 of 24345). Of the 627 samples that were reprocessed, 97.3% (610 of 627 TP samples) were changed from unsatisfactory to satisfactory. Of these 610 satisfactory reprocessed paps 81% (495) were negative for intraepithelial lesion or malignancy, 8.6% (53) were atypical squamous cells of undetermined signifi cance, 0.81% (5) were atypical glandular cells of undetermined signifi cance, 4.4% (27) were low-grade squamous intraepithelial lesions, 1.5% (9) were high-grade squamous intraepithelial lesions, 0.67% (4) were carcinoma and 2.8% (17) were 'other' category. Conclusions: Reprocessing unsatisfactory ThinPrep Papanicolaou smears with glacial acetic acid serves as a useful tool for reducing unsatisfactory rate and enhancing cervical disease detection. Background: The national drive towards establishing a comprehensive Electronic Medical Record (EMR) underscores the importance of accuracy of such records. ACGME specifi cally requires training programs to educate residents in identifi cation and prevention of human/system errors and implementation of solutions, as components of practice-based learning and improvement, and systems-based practice. Our previous study of root cause analysis of surgical pathology reports released on the wrong patients revealed that incorrect entry of patient or specimen information occurred most frequently in the operating room (OR), due to high volume of specimens received from the OR. The objective of our current study is to prevent errors through implementation of mandatory "pathology specimen time-out" (PSTO) in our institution's OR policy. Here we report results of our performance improvement measure for reducing patient/ specimen misidentifi cation by the OR. Design: We implemented mandatory PSTO in our OR policy in June 2010. PSTO was defi ned as "patient re-identifi cation and re-confi rmation of specimen site and laterality" at the time of acquisition of the specimen in the OR. Subsequently, all amended surgical pathology reports released on wrong patients from July 2010 through August 2011 were reviewed. In addition, we reviewed all "near-misses" from OR, defi ned as "improper or incorrect patient and/or specimen identifi cation recognized by pathology staff before completion and release of report," thus preventing patient or specimen misidentifi cation and avoiding an amended report. Results: Before institution of the mandatory PSTO, 16 reports were released on wrong patients out of a total of 50,000 surgical pathology reports from January 2006 to June 2010 at our institution. In the subsequent 13 months following institution of mandatory PSTO, 4 reports were released on wrong patients out of a total of 14,000 surgical pathology reports, and none of these amended reports occurred due to OR entry error. All 4 amended reports were a result of entry error at clinics where mandatory PSTO had not been implemented. In addition, there was a progressive decline in "near misses" from the OR during this 13 month period. Conclusions: Mandatory PSTO implementation in the operating room is an effective preventive mechanism for reducing patient/specimen entry errors into EMR, thus contributing to patient safety and should be adopted as a national/global standard of care.
Clinician Compliance with Laboratory Regulations Requiring Submission of Appropriate Clinical Data: A One Year Retrospective
Analysis LJ Layfi eld, RE Factor, EA Jarboe. University of Utah, Salt Lake City, UT; ARUU Laboratories, Salt Lake City, UT. Background: The evaluation of tissue samples submitted to Surgical Pathology is a consultation composed of evaluation of pertinent patient history, clinical fi ndings and morphologic analysis. The College of American Pathologists (CAP) recognizes the need for clinical data in the interpretation of specimens submitted for histopathologic evaluation. The CAP regulation (CAP GEN.40100 Specimen Collection Manual Elements) includes instructions for a number of elements which include the need for appropriate clinical data, when indicated. In a note they state, "Because of the importance of clinical information in the practice of Surgical Pathology and Cytopathology, requisitions for such specimens should include pertinent clinical data, as well as preoperative and postoperative diagnosis." Anecdotal evidence indicates that clinician compliance with such requests is variable and at times poor. Design: ARUP Laboratories and the Department of Pathology at the University of Utah have recognized inclusion of clinical history on Surgical Pathology request forms as a clinical indicator for quality assurance. The quality assurance data from August 1, 2010 to September 31, 2011 were searched for all cases fl agged as containing no clinical history. Additionally, four consecutive weeks of Surgical Pathology request forms were reviewed to determine the presence or absence of clinical history, correlation was made with specimen type and clinical service requesting the pathology consultation. QA data was also reviewed to determine if the clinical history was accurate. Results: Between August 1, 2010 and July 31, 2011, 21,700 surgical pathology cases were accessioned. Within this group, 1,293 (5.9%) requisitions contained no clinical history. The four week review found that 140 of 1,698 (8.2%) of requisitions contained no clinical history or only a specimen site of origin. This analysis also revealed that 4 cases contained substantially incorrect or incomplete clinical history (0.2%).
Conclusions:
Our review indicates a signifi cant number (5.9%) of requisitions contain no clinical history on the request form. A more in depth review reveals that approximately 8% contain either no clinical history or simply a body site in the clinical history request area and in 0.2% of cases, the clinical history was factually incorrect. Compliance with requirements for clinical history is poor and reveals the need to educate clinicians to provide this information.
Use of GEWF Solution in the Gross Examination of Colorectal Adenocarcinoma Resection Specimens Is Associated with Increased Lymph Node Yield but Not Improved Survival
HH Li Chang, K Newell, DK Driman. University of Western Ontario, London, ON, Canada; Grey Bruce Health Services, Owen Sound, ON, Canada. Background: The number of lymph nodes identifi ed in colorectal adenocarcinoma (CRC) resection specimens correlates positively with clinical outcomes. The identifi cation of a greater number of lymph nodes increases the likelihood of appropriate staging, and the identifi cation of 12 lymph nodes is a key quality measure for colon cancer care. Rectal resections and some colon resections may be associated with suboptimal lymph node yields (LNY). GEWF solution (glacial acetic acid, ethanol, water, formalin) is a safe, simple, and inexpensive lymph node highlighting (not fat-clearing) solution that has been demonstrated to result in signifi cantly improved lymph node retrieval. Whether its use is associated with improved clinical outcomes has not been studied. Design: Patients with stage I-III CRC who underwent primary surgical resection at two partner institutions were selected sequentially from 2002-2004; an a priori power analysis was performed to determine an adequate sample size for detecting survival benefi t. GEWF solution was routinely used for lymph node retrieval in the study group and not in the control group. Clinical and pathologic features including LNY, diseasefree survival (DFS), and overall survival (OS) were compared. Results: One hundred fi fty-three resections were examined using GEWF solution, and 169 resections were examined without GEWF. Use of GEWF solution was associated with signifi cantly greater LNY (21.0 ± 10.1 vs. 13.2 ± 7.2, P < 0.0001) and a greater number of positive lymph nodes (1.7 ± 3.5 vs. 1.1 ± 2.2, P < 0.05). Twelve or more lymph nodes were more frequently identifi ed in specimens examined with GEWF (82.4% vs. 50.0%, P < 0.0001). Use of GEWF was more often associated with adequate LNY in rectal specimens (80.0% vs. 37.9%, P < 0.05) and specimens measuring ≤ 15 cm in length (68.9% vs. 48.4%, P < 0.05). No differences in DFS or OS were noted between the two groups (mean follow-up = 63.2 ± 27.7 months). The two groups were otherwise similar with respect to patient and tumor characteristics. Conclusions: Use of GEWF solution in the gross examination of CRC specimens is associated with improved LNY and a larger number of positive nodes. Although routine use of GEWF does not lead to improved patient outcomes, laboratory quality measures may be more readily achieved with its use, particularly when assessing problematic specimens.
Communicating Diagnostic Uncertainty in Surgical Pathology
Reports: Disparities between Sender and Receiver SW Lindley, LA Hassell, EM Gillies. University of Oklahoma, Health Sciences Center, Oklahoma City, OK. Background: Conveying diagnostic uncertainty in surgical pathology is a daily practice however there is no standardized wording for communication of uncertainty to clinicians. Design: Attendees at multi-disciplinary tumor boards completed an anonymous survey that asked them to estimate the degree of certainty associated with eight diagnoses. One diagnosis contained no expression of uncertainty while the other seven contained the following phrases: cannot rule out; consistent with; highly suspicious; favor; indefi nite for; suggestive of; and worrisome for. A total of 57 responses were received. Results: For analysis the respondents were divided into the following groups: medical students, residents, fellows, attendings, medicine/medical subspecialties, pathologists/ radiologists, and surgeons. The variations in the level of perceived certainty is quantifi ed by the standard deviations from the means (table 1) and shown graphically (Figure 1 ). 
Conclusions:
We found that all groups show marked variability between respondents in the degree of certainty they associated with the phrases. The high standard deviations for all phrases indicate that there is substantial ambiguity in these terms, even amongst pathologists who routinely use these phrases in their own reports. These preliminary fi ndings highlight the need for more explicit communication of uncertainty between pathologists and clinicians. Clearly, we are not adequately communicating our intended level of diagnostic uncertainty with the phrases studied here. This communication gap opens the door for medical errors. While a more extensive study is necessary, we see the need to foster dialogue and actions to insure more accurate communication. Multiple regression analysis of LN counts using independent variables of pathologist, surgeon, organ weight, patient age, Gleason score, presence of metastases, extracapsular extension, extensive perineural invasion, lymphovascular space invasion, surgical stage and the number of LN packets submitted found that only the number of node packets was a statistically signifi cant factor in the number of LNs counted (p=<0.0001). Quartile analysis of all pathologists showed that the lowest quartile (Q1) reported 5.5 fewer LNs on average than the top quartile (Q4, p=<0.0001, 95% CI 3.4 to 7.6 nodes). In the cases where only two LN packets were submitted, Q1 reported 3.5 fewer LNs when compared to Q4 (p=0.0009, 95% CI 1.5 to 5.5). Q2 and Q3 also reported signifi cantly fewer nodes than Q4 for all cases (p=0.001 and 0.007, respectively) and for those cases where only two LN packets were submitted (p=0.0012 and 0.026, respectively).
Interobserver Variability of Lymph Node Count in Pelvic Lymph
Conclusions:
Interobserver agreement in LN counts in PLND is very poor. Analysis of LN counts by all pathologists at our institution indicate that counting may be biased, since the top quartile of pathologists reports signifi cantly more nodes than the other three, even when controlling for the most signifi cant factor affecting LN counts (number of packets submitted). These data suggest that pathologists do not use the same criteria for LN counts and calls into question studies use LN counts as a metric of clinical outcome or quality of surgery or pathology. We recommend developing a national consensus for how pelvic LNs are counted. An elevation of AF WBC over 50 cells/mm 3 has been reported to be 36-64% sensitive and 72-95% specifi c for IAI. However, cell count on amniotic fl uid is not routinely performed in the laboratory, nor is it offered at any of the major reference labs. At the request of clinicians, accuracy of manual AF WBC count was determined. Design: Ten AF samples sent to the laboratory for routine AFP measurement were randomly selected for analysis. Two technologists performed cell counts on each sample using a hemocytometer. A total of 100 fi elds were counted. To assess accuracy of WBC counts at various concentrations, AF samples that had no WBCs were spiked with blood from CBC specimens with known WBC counts, producing samples with calculated WBC counts ranging from 11-195 WBC/μL. Cell counts were performed on the ten spiked samples, including a negative control. The WBC counts for all 20 specimens were then compared to the calculated expected value for WBC. Results: No debris was reported. The initial WBC count on the non-spiked samples ranged from 0-4/mm³. Comparison between the technologists' manual WBC count on the spiked samples to the expected WBC count yielded R 2 coeffi cients of 0.51 and 0.83. When technologist results were averaged together, the R 2 coeffi cient between the manual count and the expected WBC count was 0.66. Percent agreement between the technologists was 80%, with an R 2 coeffi cient of 0.83. The average CV was 21% with a range of 0-62% for each sample.
There was moderate correlation between the manual and the expected WBC in the spiked AF samples. The coeffi cient of determination from the averaged results was lower than usual acceptable criteria. Using a threshold of 50 cells/mm 3 as the cutoff for infection, one sample would have erroneously been reported as less than 50, while the expected count was 54 cells/mm 3 . The accuracy of the WBC count may be increased by averaging the WBC counts reported by two technologists. The decision to perform amniotic fl uid cell counts should involve a discussion with clinicians about the accuracy of the test and the potentially high CV associated with this test. Background: A systematic approach to rare defects is a major challenge in surgical pathology continuous quality improvement. Patient misidentifi cations (patient misIDs) are infrequent but major defects in the surgical pathology process. Design: We investigated the distribution throughout the entire surgical pathology testing process of defects that led to amended reports. Among 315 amendments in 2010, as we we processed 63,308 cases [5 amendments /1000 cases], 31 amendments were due to misidentifi cations [9.5 %], 8 to specimen defects [2.5 %], 16 to misinterpretations [5%], and 260 to report defects [83%] (Report defects were errors that did not involve misidentifi cations, specimen problems, or misinterpretations.) Of the 31 misidentifi cations, 6 were errors in determining laterality, 2 errors that designated the wrong tissue, and 1 error in designating location within a tissue. The remaining 22 misidentifi cations were of pateints. We specifi ed the root cause for all of these 22 cases.
Results: Among more than 63,000 surgical specimens, 22 patient misIDs [3.5 misIDs/10,000 specimens] were indeed rare events. 13 (59%) occurred before arrival in the pathology department: 3 at patient registration (2 involving patient impersonation and 1 confusing mother and daughter), 10 at specimen collection: 5 skin biopsies in dermatologists' practices; 2 endometrial biopsies, one in a clinic, one in an emergency department; 2 placentas from two different labor and delivery units, and 1 transplant kidney biopsy from nephrology. Of the 9 patient misIDs in the pathology department, 3 skin biopsies, 3 liver biopsies, and 1 prostate case were confused at pathologist signout; 2 colon biopsies were confused at microtome sectioning. Conclusions: Biopsies accounted for 16/22 (73%) and skin biopsies alone for 8/22 (36%) of all patient misIDs. The physical similarity of biopsies from different patients -at collection (8/10 cases) and at sign-out session (5/7 cases)-emerged as the main root cause. The same root cause also appeared for placentas confused at the point of colection and for GI biosies confused at microtome sectioning. Physical similarity lastly appears as the cause of confusion at specialty sign-out for standardized prostate resections. For the 19/22 patient misIDs that were not primary registration errors, failing to distinguish between grossly identical specimens was the root cause in all cases detected, both external and internal to the pathology department. Conclusions: Specimen sampling errors were more common in Neuropath cases likely due to surgical diffi culties in accessing the tumor tissue. Deferrals and interpretation errors were more common in paediatric cases, caused by high frequency of small round cell tumors and congenital disorders that was diffi cult to diagnose in the intraoperative setting. Lessons learned from detailed analysis of the data could help to reduce errors, reduce the number of deferrals and improve the accuracy of frozen section diagnosis. Conclusions: Inadequate marrow trephine core biopsy length contributes signifi cantly to discordant diagnostic data, creates interpretive pitfalls, and can lead to a false negative morphologic diagnosis in staging bone marrow biopsies. This diagnostic disparity can potentially lead to inaccurate clinical staging. The outcome of upstaging disease status based on positive ancillary data, independent of marrow morphology is unclear at this time. Background: Lung transplantation is an established treatment modality for patients with end-stage lung disease. Surveillance for rejection is based on spirometry parameters and pathologic evaluation of protocol biopsies in stable grafts; additional biopsies are performed for clinical indications in failing grafts. However, the detection of rejection is dependent on the observer's experience in allograft pathology interpretation. We sought to compare the % of reporting of rejection by general surgical pathology versus sub-specialty sign-out. Design: We reviewed all lung transplant biopsies performed at our institution between 2005 and 2010 for the reported degree of rejection, underlying lung pathology leading to transplantation, age at the time of biopsy and correlated the results with the type of sign-out (general versus subspecialty). 1034 lung biopsies from 224 patients were reviewed; 41 patients who were < 40 years old all suffered from cystic fi brosis while 183 patients who were > 40 years old suffered primarily from idiopathic pulmonary fi brosis and COPD. Prior to 2008, lung transplant biopsies were handled by general pathologists but since 2008 this is done by a sub-specialty sign-out. table) doubled with subspecialty sign-out: 10.5 versus 22.5%. While this was mainly due to increased reporting of A1, there was also a 70% increase in the reporting of clinically signifi cant (A2) grades of rejection. Moreover, reporting of minimal rejection (A1) was clinically helpful in patient management and planning for a possible re-biopsy. There was no statistically signifi cant difference in reporting rejections in different patient age-groups and underlying lung pathology. Conclusions: Introduction of sub-specialty sign-out doubled the overall % of reported rejections and, most importantly, increased by 70% the reporting of clinically signifi cant, A2, rejections. While the latter leads to an immediate change in clinical management, the reporting of minimal rejection (A1) has also been helpful in overall patient management. Our study further supports the advantages of sub-specialty sign-out as an important quality assurance measure in surgical pathology.
Potential Diagnostic Pitfalls Related to Bone Marrow Biopsy Quality in Staging Diffuse Large B-Cell Lymphoma
A Method for Decreasing Interobserver Variability in Quantitative HER2
Immunohistochemistry DP Ng, LJ Dumont, GJ Tsongalis, VA Memoli. Dartmouth Hitchcock Medical Center, Lebanon, NH. Background: Over-expression of the HER2 receptor is associated with aggressive breast cancer development. The highly specifi c immunotheraputic targeting of HER2 by mABs and TKIs, as well as, the high cost of these treatments make accurate assessment of HER2 status essential. Currently, the main techniques used to assess HER2 status are FISH and IHC. FISH is limited to laboratories with fl uorescent microscopy capabilities while IHC is the most prevalent technique for quantifying HER2 status. However, quantitative immunohistochemistry (qIHC) shows poor reproducibility between observers. Here we report a method to decrease inter-observer variability in HER2 qIHC through the inclusion of reproducible standard controls. Design: Four immortalized cancer cell lines with consistently differing levels of HER2 expression (MCF-7, BT-20, MDA-MB-453 and SKOV-3) were grown, pelleted, formalin fi xed and paraffi n embedded. Control strips were made from 2 mm cores of these cell lines. Eight cases of breast carcinoma known to express HER2 as previously assessed by FISH were cut on a slide with the control strips. The optimum incubation and concentration of a mAB (CB11) for HER2 was found such that an intensity breakpoint was seen between 2+ and 3+ staining patterns corresponding to a HER2/CEP17 ratio of 1.8. Next, an additional 19 cases of breast carcinoma with HER2/CEP17 ratios ranging between 1.0 and 7.2 were evaluated by 5 pathologists using the control strip in addition to ASCO guidelines. Five additional pathologists assessed HER2 status without the control strip. The data was analyzed using Fleiss' correlation and chi-square analysis.
Results: The analysis of HER2 expression by use of control strips and ASCO guidelines signifi cantly decreased inter-observer variability compared to analysis using only ASCO guidelines, (k=0.5686 vs k=0.4337) with a mean difference of 0.1349 (95% CI 0.0591 to 0.2107). Receiver Operating Characteristic curves for the experimental group showed an area-under-curve (AUC) of 0.888 while the control group showed an AUC of 0.856 (not signifi cant).
Conclusions:
We describe a new method for decreasing inter-observer variability using qIHC to score HER2 expression. These control strips are easily made from cultured cells and provide suffi cient control material to run a large number of quantitative tests. qIHC may serve as a useful and important tool in determining HER2 status in small laboratories lacking the ability to assess HER2 status by FISH or in specimens with small tumor foci where FISH may fail.
Design: A pilot survey was conducted by QMPLS in 2010. The participants were asked to download the viewing software Image Scope provided by Aperio. QMP-LS distributed the software to 51 participants within Ontario. The participants were asked to view and analyze eight digital images obtained from various preparation techniques and body sites. Results: Over 85% of participant responses matched the assigned value, except for one case of a respiratory bronchial washing conventional smear, where the thickness of the sample interfered with visualization of the malignant cells. The results showed that LB preparation slides are better suited for DM since they have smaller areas to scan. The image quality and the ability to focus on the image and cells were the two most important factors for successful application of DM in PT. One of the main hurdles was downloading the Image Scope software because of hospitals' and community laboratories' fi rewalls, though after reconfi guring fi rewall and proxy settings all participants were able to proceed with the survey. Conclusions: By using digital images, External Quality Assessment (EQA) programs can provide the means for participants to view and interpret microscopic preparations of small volume, unique or diffi cult to obtain patient material for assessment and/or education. The benefi ts of this technology are conducive to revolutionizing traditional cytology surveys. The pilot survey identifi ed optimal sample types for future DM surveys and the the feedback will help guide QMP-LS in using DM in future surveys. Background: Communicating the frozen section (FS) diagnosis to the surgeon is a critical component of the FS process. Unfortunately, this often involves reporting a diagnosis via telephone to operating room (OR) staffs other than the surgeon. This may lead to miscommunication and thereby affect patient care. The aim of this study was to evaluate the accuracy of communicating FS diagnoses during intra-operative consultations at our institution. Design: A total of 300 consecutive cases, where a FS was performed (9 month in 2009), were retrieved from the anatomic pathology laboratory information system (CoPath, Cerner). Cases were included if there was a corresponding OR note in the electronic medical record which described the surgeon's interpretation of the FS diagnosis. Preoperative diagnosis, intra-operative question, specimen type, FS diagnosis (called to the OR), surgeon's interpretation, fi nal pathologic diagnosis and patient outcome (per clinical notes) were recorded for all cases. Discrepancies between the FS diagnosis and surgeon's interpretation were recorded as a miscommunication and further classifi ed as major (clinical impact) or minor (no clinical impact).
Results: A variety of specimen types were received for FS requesting a diagnosis (59.3%), margin status (30.6%), both a diagnosis and margins (6.6%), or lymph node status for cancer (3.5%). There were 8 (2.6%) miscommunications, all of minor clinical impact, most (88%) of which had a FS diagnosis that was deferred to permanents. Miscommunications in these cases involved reporting "loaded" neutrophils in bone tissue, deferred grading for a sarcoma, interpretation of margins as "excellent" for urothelial dysplasia at ureteral margins, interpretation of a low grade spindle cell proliferation as an infl ammatory lesion by the surgeon, and partial documentation in the OR note of two specimens that were submitted for FS diagnosis. In 6 other cases (2%) FS and fi nal pathologic diagnoses were discrepant; however there was no miscommunication of these FS diagnoses to the OR.
The rate of miscommunicated FS diagnoses to surgeons was low at our institution with no adverse patient outcome. Reporting of FS diagnoses using non-standard terminology and indeterminate diagnoses (ie. deferrals) were the most frequent cause for miscommunication. Miscommunications may be circumvented by maintaining a good working relationship with surgeons, requesting immediate acknowledgement following a verbal FS diagnosis and displaying the FS diagnosis in real-time on a monitor in the OR.
Receiver Operating Characteristics (ROC) Application to Immnuhistochemistry for Determining Optimal Antibody Concentration: A Mathematical and Novel Application for Quality Control TD Samulski, T Baradet, PD Zhang, P Lal, MS Feldman, KS Gustafson, EE Furth.
Hospital of the University of Pennsylvania, Philadelphia, PA; Fox Chase Cancer Center, Philadelphia, PA. Background: No standards exist by which working antibody concentrations are determined in clinical immunohistochemistry (IHC) laboratories. Such decisions are made by microscopic examination of the staining intensity of differing antibody concentrations using selected tissue sections, and choosing an "optimal" concentration (that which yields the stongest true staining and weakest false staining) "by eye." We utilized a mathematical approach derived from signal detection theory, receiver operator characteristics, coupled with computer image analysis to create a quantitative algorithm for IHC optimization. Design: Immunohistochemical staining of formalin-fi xed paraffi n embedded normal kidney tissue using antibodies against Multi-cytokeratin AE1/AE3 (Novocastra; Wetzlar, Germany; #NCL-AE1/AE3) was performed at concentrations 1:1, 1:2, 1:4, 1:40, 1:400, 1:4,000, 1:40,000, and 1:400,000 using standard methods on a Leica Bond instrument using the Novocastra Bond Polymer Refi ne Detection System. For each antibody concentration, the signal intensity of the tubules (biologic positive) and interstitium (biologic negative) per cell was measured by InForm® data collection software. The area under the curve (AUC), as metric of test performance and standard deviation were calculated. Considering each dilution as an individual "test", we compared the AUC among each "test" and chose the "test" with the highest AUC as the optimal antibody concentration.
Results: The performance of the AE1/AE3 antibody was high across most antibody dilutions (1:1, 1:2, 1:4, 1:40, 1:400, 1:4,000, 1:40,000, and 1:400,000) despite dropping signal intensity. For each respective antibody dilution the AUC was 0. 97, 0.91, 0.94, 0.99, 0.97, 0.98, 0.5, and 0.5 (S.D. <.0001 )and the average tubule signal was 0. 28, 0.22, 0.22, 0.34, 0.19, 0.13, 0, and , and error type (e.g., transposition of numbers, "one-off" shift in digits). Logistic regression was used to explore associations between errors and causal factors such as daily case load, time of day, day of week, case complexity and employee category. Quality analysis tools such as a process fl ow diagram, a control chart, cause and effect diagrams and "fi ve-why" analysis were used to explore causal relationships.
Results: 85 labeling errors were identifi ed in 42,684 specimens processed during the study period. The error rate was stable over this period and was almost 10 times higher for residents than for regular staff (p<0.001). The error rate varied by specimen type being lowest for dermatology specimens (p< 0.001). Among non-dermatology specimens, the error rate was signifi cantly higher for complex specimens (p<0.001).
Errors were unassociated with daily case load, day of week or time of day; there was a signifi cant increase in errors at the end of the day on Friday and Saturday. Errors were evenly divided between within-case and between case errors. Root cause analysis identifi ed work space crowding, cassette printer design and cassette handling mechanisms as possible contributors to error. Conclusions: Labeling errors are associated with specifi c factors (employee type, specimen type and particular time periods). Improved supervision of house staff and error prone processes may reduce labeling errors. Increased oversight of labeling of complex specimens and specimens processed during particular times of days may improve specimen labeling. The main cause for discordant preliminary and fi nal diagnoses in cases with ROSE was the lack of site specifi c/diagnostic tissue on preliminary smears, suggesting that liquid based preparations and cell blocks may offer advantages for processing these specimens. Despite the benefi ts of ROSE, in this era of personalized medicine and increasing health-care costs, forgoing ROSE may lead to cost savings as well as increased diagnostic material available for immunohistochemical and molecular testing in EBUS-TBNA specimens. . When these errors are identifi ed and corrected during the analytical phase, they constitute a "near-miss." If they are identifi ed afterwards, they are misses. Many groups now encourage a variety of processes to detect identifi cation errors during the analytical phase. Nonetheless, some identifi cation errors escape detection during the analytical phase and result in post-analytical errors which may have consequences.
In this study, we investigate the details of post-analytical phase identifi cation errors. Design: Surgical pathology and cytopathology reports from 2008 to 2011 with subsequent amendments were identifi ed. The reports and original requisitions were reviewed to classify the error by the subspecialty service involved, type of error, source of error, and the personnel involved in identifying the error. Results: We identifi ed 75 cases with subsequent amendments. The errors involved all anatomic pathology subspecialties ( Table 1) . The most frequent type of error was the "wrong anatomic site" provided on the requisition form ( Table 2 ). The source of error was attributed to the submitting clinical staff in 59%, pathology department in 36%, and other sources in 5% of cases. Identifi cation of the errors was made by clinicians in 60% of the cases, pathology department personnel in 34%, others in 6%. Signed reports using "Manual" and eCC methods were compared for 1) percentage of cases containing all required elements, and 2) number and type of missing required elements. If data elements were not applicable to the specimen they were not counted in the total. Results: 758 "Manual" and 341 eCC reports were analyzed (see Table for results).
The most common missing elements in "Manual" reports were margins/distance to margin (92 breast, 20 lung, 6 colon), presence/absence of lobular carcinoma in situ (57 breast), ancillary studies (39 breast), and evaluation of non-neoplastic kidney (19 kidney). Only four eCC reports had a missing element: distance to margin (3 lung) and ancillary studies (1 breast). Conclusions: Switching to eCCs dramatically improved the percentage of cancer reports containing all required elements (from 68.6% to 98.8%). For certain required elements in "Manual" reports, it was often not clear if the element was missing due to an oversight or because it was not applicable to the specimen. The consistent use of "absent" or "N/A" in eCC reports for such elements eliminated this ambiguity. Overall, laboratories using manual methods should consider changing to eCCs in order to increase compliance with cancer reporting requirements. Additionally, day-to-day hue variability was signifi cantly decreased using an automated stainer (Pre-and post-automation hue standard deviations 22.4 and 6.8, respectively).
Conclusions:
Initiation of automated staining yielded signifi cant changes in hue and saturation and decreased day-to-day staining variability. Digital HSV analysis can be a viable method of objectively assessing stain quality and variability within the histology laboratory. Using acceptable hue and saturation error levels, histologic stain quality can be quantitatively assessed in similar fashion to analytical tests within the clinical laboratory. Results: Of the 31 cases evaluated, 16 were women and 15 were men, with ages ranging from 48 to 87 years (mean 54 years). The sizes of the adrenal masses ranged from 1.2 cm to 8.0 cm. 71% (22 cases) were detected as part of the work-up of metastatic disease, while the remaining 9 lesions (29%) were found incidentally. The incidental lesions ranged in size from 2.0 to 8.0 cm, with a mean of 3.7cm. Of all 31 cases, 18 (58%) showed satisfactory concordance between the cytology fi ndings and the radiologic impression, while 10 (32%) were discordant, and 3 had imaging done at an outside hospital. Of the 10 discordant cases, all were suspected to be metastatic disease radiologically, based on masses detected elsewhere and/or positron emission tomography (PET) status. Each of the cases was found to be a benign lesion upon FNA. 9 (90%) of the discordant cases were adrenal masses less than 3.0 cm in size.
Pitfalls in Flow Cytometry
In this study cohort, only four cases had subsequent resection specimens. All of the surgical resctions correlated with the original FNA interpretation, with 2 cases as primary adrenal neoplasm (3.0 cm and 4.5 cm) and 2 cases as metastatic carcinoma. Conclusions: Adrenal gland FNA is mainly reserved for masses suspected to represent metastasis. Radiologic and FNA discordance is fairly frequent (32%) and most common with lesions less than 3.0 cm. Therefore, FNAs of adrenal masses should be used in a more selective fashion, especially when measuring less than 3.0 cm. (54) 20 (40) 13 (26) Conclusions: The quality of GI mucosal biopsy slides were signifi cantly improved after a simple and feasible program. Educating and training medical personals involved in tissue procurement and tissue processing are crucial. Benefi ts from these high quality slides will be further investigated. In total, 46 issues (1.76%) were identifi ed including 7 (0.27%) in the pre-analytic phase, 1 (0.034 %) in the analytic phase and 38 (1.46%) in the post-analytic phase. In the pre-analytic phase, there was inadequate clinical history in 4 cases, wrong patient's DOB in 1 case, wrong clinician's name in 1 case, and a grossing error in 1 case (failure to identify two separate tumor nodules in a lung specimen). In the analytic phase there was one false positive margin status due to the presence of therapy artefact. In the post-analytic phase: 16 cases had a change in pathologic staging; 15 cases had typographical errors, and 7 cases had incomplete CAP reporting. Conclusions: Review of tumor board cases can be used as an internal benchmark to monitor error rate in surgical pathology in the pre, post and analytic phases. In our series, patient care benefi ted from this review in at least 25 cases (0.9%) in which therapy, and prognosis were affected when pathologic staging was changed, CAP reports added important missing information, and one margin was found to be negative rather than positive. Design: This initiative is designed to implement 2D barcoding throughout Anatomic Pathology and Histology. 2D barcodes on specimen labels, tissue cassettes and slides contain patient, specimen, and tissue section specifi c information. Specimen labels, cassettes and slides are printed on demand to support single piece fl ow throughout the system. Custom programming in the Cerner Millennium Laboratory Information System (LIS) performed by the Laboratory's IT Specialist enables the print devices to access specifi c case and block information. Tissue cassettes are printed on Thermo-Scientifi c Microwriters at the time of specimen setup. Technicians are instructed to work on one case at a time, and each cassette has a corresponding 2D barcode linking it to the LIS with case and block identifi cation data. Each histotech is provided with a slide writer, the Thermo-Scientifi c Slidemate. The histotech scans the block which interfaces with the LIS. The slide writer prints all slides based on requests pending for that block. The slides are verifi ed in the LIS when completed, and subsequent requests can be entered and printed for recuts and special stains. Results: During the baseline period (March -May, 2011), the laboratory averaged 2.5 mislabeled blocks per 1000 and 0.086 mislabeled slides per 1000. The data for the implementation month (June) were not counted as several process adjustments were required during that time. During the three months post implementation (July -August), the laboratory averaged 0.7 mislabeled blocks per 1000 and 0.017 mislabeled slides per 1000 resulting in a 73% and 80% improvement, respectively.
Conclusions:
The utilization of barcode technology coupled with single piece throughput offers a safer system in terms of maintaining the integrity of specimen labeling throughout the system. Mislabeling events still occur. Data collection in Surgical Pathology is now enhanced to identify where in the process errors occur, i.e. during setup of specimens, reprinting of cassettes, or gross dissection of specimens. Additional process redesign is planned to address these errors when the areas of greatest risk are identifi ed. In this study, we attempted to examine the properties of speicmens that may contribute to failure. The fi ndings will help clinicians and pathologists choose the optimal specimens for EGFR mutational study. Design: For EGFR mutation testing in our institution, speimens were fi rst tested for the common mutations, including exon 19 deletion by fragment analysis and L858R by melting curve analysis following PCR amplfi caiton. Negative cases were subsequently
